Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell entry by SARS-CoV-2
Ruchao Peng, Lian-Ao Wu, Qingling Wang, et al.
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 10, pp. 848-860
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 291
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 223
ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress
Di Chen, Qiaoxia Zheng, Long Sun, et al.
Developmental Cell (2021) Vol. 56, Iss. 23, pp. 3250-3263.e5
Open Access | Times Cited: 156
Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1
Linjie Li, Hanyi Liao, Yumin Meng, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2952-2960.e10
Open Access | Times Cited: 143
Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells
Rémi Planès, Miriam Pinilla, Karin Santoni, et al.
Molecular Cell (2022) Vol. 82, Iss. 13, pp. 2385-2400.e9
Open Access | Times Cited: 109
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
Jim Baggen, Maarten Jacquemyn, Leentje Persoons, et al.
Cell (2023) Vol. 186, Iss. 16, pp. 3427-3442.e22
Open Access | Times Cited: 101
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 74
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
Fanchong Jian, Jing Wang, Ayijiang Yisimayi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 20
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Mengfei Chen, Andrew Pekosz, Jason Villano, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 17
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1759-1759
Open Access | Times Cited: 58
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
Enya Qing, Pengfei Li, Laura Cooper, et al.
Cell Reports (2022) Vol. 39, Iss. 5, pp. 110786-110786
Open Access | Times Cited: 51
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor
Oded Danziger, Roosheel S. Patel, Emma J. DeGrace, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 4, pp. e1010464-e1010464
Open Access | Times Cited: 47
SARS-CoV-2 down-regulates ACE2 through lysosomal degradation
Yi Lu, Qingwei Zhu, Douglas Fox, et al.
Molecular Biology of the Cell (2022) Vol. 33, Iss. 14
Open Access | Times Cited: 43
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
Bo Meng, Rawlings Datir, Jinwook Choi, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111220-111220
Open Access | Times Cited: 41
SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry
Bo Yang, Yuanyuan Jia, Yumin Meng, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 4
Open Access | Times Cited: 40
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 40
Precise Assembly of Proteins and Carbohydrates for Next-Generation Biomaterials
Long Li, Guosong Chen
Journal of the American Chemical Society (2022) Vol. 144, Iss. 36, pp. 16232-16251
Closed Access | Times Cited: 39
Advances in developing ACE2 derivatives against SARS-CoV-2
Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e369-e378
Open Access | Times Cited: 39
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V. Tse, Yixuan J. Hou, Elizabeth McFadden, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Open Access | Times Cited: 24
Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1
Ilyas Khan, Sunan Li, Hongtao Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 10
Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins
Francesca R. Hills, Jemma L. Geoghegan, Mihnea Bostina
Virology (2025), pp. 110383-110383
Open Access | Times Cited: 1
Inflammasome Activation by RNA Respiratory Viruses: Mechanisms, Viral Manipulation, and Therapeutic Insights
Tamara Silva Rodrigues, Dario S. Zamboni
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Zhenfeng Wang, Shunshun Li, Bo Huang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top